Literature DB >> 15136793

Antagonism by NOS inhibition of the behavioral effects of benzodiazepine and GABAA receptor agonists in the mouse elevated plus-maze.

Geraldine S Elfline1, Emily M Branda, Michael Babich, Raymond M Quock.   

Abstract

Earlier we implicated nitric oxide (NO) in mediation of the behavioral effects of benzodiazepines. Since benzodiazepines work through facilitation of GABAergic inhibitory neurotransmission, this study was designed to determine whether the direct-acting gamma-aminobutyric acidA (GABAA) receptor agonist THIP (4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol) evokes behavioral effects similar to those of benzodiazepines and whether behavioral effects of THIP are also NO dependent. When challenged with either chlordiazepoxide or THIP in an elevated plus-maze paradigm, male NIH Swiss mice exhibited a dose-related increase in open-arm activity. The chlordiazepoxide-induced effects were sensitive to antagonism by a benzodiazepine antagonist, and the effects of THIP were blocked by a GABAA receptor antagonist. Pretreatment with the NO synthase (NOS) inhibitor L-NG-nitro arginine antagonized the effects of both chlordiazepoxide and THIP; similar pretreatment with the D-isomer, D-NG-nitro arginine, which is inactive as an NOS inhibitor, was without effect on chlordiazepoxide and THIP. These findings indicate that chlordiazepoxide and THIP evoke similar behavioral effects in mice in the elevated plus-maze through actions on different parts of the GABAA receptor, and that NO appears to play a key role in mediation of the behavioral effects of both chlordiazepoxide and THIP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15136793     DOI: 10.1038/sj.npp.1300437

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  8 in total

1.  The nitric oxide donor sodium nitroprusside attenuates recognition memory deficits and social withdrawal produced by the NMDA receptor antagonist ketamine and induces anxiolytic-like behaviour in rats.

Authors:  Aikaterini Trevlopoulou; Ntilara Touzlatzi; Nikolaos Pitsikas
Journal:  Psychopharmacology (Berl)       Date:  2015-12-19       Impact factor: 4.530

2.  Extrasynaptic GABAA receptor activation reverses recognition memory deficits in an animal model of schizophrenia.

Authors:  Trine Damgaard; Niels Plath; Jo C Neill; Suzanne L Hansen
Journal:  Psychopharmacology (Berl)       Date:  2010-10-19       Impact factor: 4.530

3.  Anxiolytic effects of phosphodiesterase-2 inhibitors associated with increased cGMP signaling.

Authors:  Anbrin Masood; Ying Huang; Hassan Hajjhussein; Lan Xiao; Hao Li; Wei Wang; Adel Hamza; Chang-Guo Zhan; James M O'Donnell
Journal:  J Pharmacol Exp Ther       Date:  2009-08-14       Impact factor: 4.030

4.  Dissociating anxiolytic and sedative effects of GABAAergic drugs using temperature and locomotor responses to acute stress.

Authors:  Christiaan H Vinkers; Marianne Klanker; Lucianne Groenink; S Mechiel Korte; James M Cook; Michael L Van Linn; Seth C Hopkins; Berend Olivier
Journal:  Psychopharmacology (Berl)       Date:  2009-01-24       Impact factor: 4.530

5.  Antinociceptive effects of gabapentin & its mechanism of action in experimental animal studies.

Authors:  Fatma Sultan Kilic; Basar Sirmagul; Engin Yildirim; Setenay Oner; Kevser Erol
Journal:  Indian J Med Res       Date:  2012-05       Impact factor: 2.375

6.  Conditioned Aversion and Neuroplasticity Induced by a Superagonist of Extrasynaptic GABAA Receptors: Correlation With Activation of the Oval BNST Neurons and CRF Mechanisms.

Authors:  Elena de Miguel; Olga Vekovischeva; Lauri V Elsilä; Anne Panhelainen; Esko Kankuri; Teemu Aitta-Aho; Esa R Korpi
Journal:  Front Mol Neurosci       Date:  2019-05-24       Impact factor: 5.639

7.  Hypothesis-driven investigations of diverse pharmacological targets in two mouse models of autism.

Authors:  Maya A Rhine; Jennifer M Parrott; Maria N Schultz; Tatiana M Kazdoba; Jacqueline N Crawley
Journal:  Autism Res       Date:  2019-01-17       Impact factor: 5.216

8.  Modification of NO-cGMP Pathway Differentially Affects Diazepam- and Flunitrazepam-Induced Spatial and Recognition Memory Impairments in Rodents.

Authors:  Jolanta Orzelska-Górka; Piotr Bernat; Piotr Tutka; Joanna Listos; Ewa Kędzierska; Sylwia Fidecka; Sylwia Talarek
Journal:  Neurotox Res       Date:  2019-12-02       Impact factor: 3.911

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.